BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 12060621)

  • 21. Androgen receptor expression in relation to apoptosis and the expression of cell cycle related proteins in prostate cancer.
    Amirghofran Z; Monabati A; Gholijani N
    Pathol Oncol Res; 2004; 10(1):37-41. PubMed ID: 15029260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MIB-1 (KI-67) proliferation index and cyclin-dependent kinase inhibitor p27(Kip1) protein expression in nephroblastoma.
    Ghanem MA; Van der Kwast TH; Sudaryo MK; Mathoera RB; van den Heuvel MM; Al-Doray AA; Nijman RM; van Steenbrugge GJ
    Clin Cancer Res; 2004 Jan; 10(2):591-7. PubMed ID: 14760081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer.
    Sjöström J; Blomqvist C; Heikkilä P; Boguslawski KV; Räisänen-Sokolowski A; Bengtsson NO; Mjaaland I; Malmström P; Ostenstadt B; Bergh J; Wist E; Valvere V; Saksela E
    Clin Cancer Res; 2000 Aug; 6(8):3103-10. PubMed ID: 10955790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer.
    Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S
    BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
    Zeng L; Rowland RG; Lele SM; Kyprianou N
    Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of p27/Kip1 is down-regulated in human prostate carcinoma progression.
    Fernández PL; Arce Y; Farré X; Martínez A; Nadal A; Rey MJ; Peiró N; Campo E; Cardesa A
    J Pathol; 1999 Apr; 187(5):563-6. PubMed ID: 10398122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer.
    Moul JW; Bettencourt MC; Sesterhenn IA; Mostofi FK; McLeod DG; Srivastava S; Bauer JJ
    Surgery; 1996 Aug; 120(2):159-66; discussion 166-7. PubMed ID: 8751578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. pRb2/p130 and p107 control cell growth by multiple strategies and in association with different compartments within the nucleus.
    Zini N; Trimarchi C; Claudio PP; Stiegler P; Marinelli F; Maltarello MC; La Sala D; De Falco G; Russo G; Ammirati G; Maraldi NM; Giordano A; Cinti C
    J Cell Physiol; 2001 Oct; 189(1):34-44. PubMed ID: 11573202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of Rb2/p130 and p107 in normal human tissues and in primary lung cancer.
    Baldi A; Esposito V; De Luca A; Fu Y; Meoli I; Giordano GG; Caputi M; Baldi F; Giordano A
    Clin Cancer Res; 1997 Oct; 3(10):1691-7. PubMed ID: 9815552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of EZH2, p27(kip1), BMI-1 and MIB-1 on biopsy specimens with low-risk prostate cancer in selecting men with significant prostate cancer at prostatectomy.
    Wolters T; Vissers KJ; Bangma CH; Schröder FH; van Leenders GJ
    BJU Int; 2010 Jul; 106(2):280-6. PubMed ID: 19888978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter.
    Stiegler P; De Luca A; Bagella L; Giordano A
    Cancer Res; 1998 Nov; 58(22):5049-52. PubMed ID: 9823308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
    Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
    Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107.
    Claudio PP; Howard CM; Baldi A; De Luca A; Fu Y; Condorelli G; Sun Y; Colburn N; Calabretta B; Giordano A
    Cancer Res; 1994 Nov; 54(21):5556-60. PubMed ID: 7923196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal expression of MDM2 in prostate carcinoma.
    Leite KR; Franco MF; Srougi M; Nesrallah LJ; Nesrallah A; Bevilacqua RG; Darini E; Carvalho CM; Meirelles MI; Santana I; Camara-Lopes LH
    Mod Pathol; 2001 May; 14(5):428-36. PubMed ID: 11353053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancer.
    Halvorsen OJ; Haukaas SA; Akslen LA
    Clin Cancer Res; 2003 Apr; 9(4):1474-9. PubMed ID: 12684422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell cycle regulators in multiple myeloma: prognostic implications of p53 nuclear accumulation.
    Pruneri G; Carboni N; Baldini L; Intini D; Colombi M; Bertolini F; Valentini S; Maisonneuve P; Viale G; Neri A
    Hum Pathol; 2003 Jan; 34(1):41-7. PubMed ID: 12605365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. pRb2/p130 protein expression is correlated with clinicopathologic findings in patients with oral squamous cell carcinoma.
    Tanaka N; Ogi K; Odajima T; Dehari H; Yamada S; Sonoda T; Kohama G
    Cancer; 2001 Oct; 92(8):2117-25. PubMed ID: 11596028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma.
    Singh SP; Lipman J; Goldman H; Ellis FH; Aizenman L; Cangi MG; Signoretti S; Chiaur DS; Pagano M; Loda M
    Cancer Res; 1998 Apr; 58(8):1730-5. PubMed ID: 9563491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gastric cancer and tumor growth regulation. Study of cell proliferation markers and protein complex p53/p21WAF1/CIP1/mdm-2].
    Villaseca M; Araya JC; Roa I; Roa JC
    Rev Med Chil; 2000 Feb; 128(2):127-36. PubMed ID: 10962880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.